Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use

Journal of Oral Pathology and Medicine

Volumn 31, Issue 9, 2002, Pages 505-511

  Kao, Shou Yen ^a,b,d   Wu, Cheng Hsien ^b   Lin, Shu Chun ^b   Yap, Soon Kiong ^a,b   Chang, Che Shoa ^a,c   Wong, Yong Kie ^b   Chi, Lin Yang ^b   Liu, Tsung Yun ^b,d  

^a Department of Dentistry Oral and Maxillofacial Surgery ^*  (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Betel; CYP1A1; Oral cancer; Polymorphism; Smoking

Indexed keywords

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ARECA; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION, MISSENSE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; SMOKING; UNTRANSLATED REGIONS; VALINE;

EID: 0036786245     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2002.00158.x     Document Type: Article

References (31)

1. Ponder BA. Genetic predisposition to cancer. Br J Cancer 1991; 64: 203-4.
2. Ranadive KJ, Shivapurkar NM, Gothoskar SV. Betel quid chewing and oral cancer: experimental studies on hamster. Int J Cancer 1979; 24: 835-43.
3. Pindborg JJ, Perersen BR, Mehta FS. Tobacco-induced in oral leukoplakic epithelium. Cancer 1980; 45: 2330-6.
4. Rao AR. Modifying influences of betel quid ingredients on B(a)P-induced carcinogenesis in the buccal pouch of hamster. Int J Cancer 1984; 33: 581-6.
5. Marshall JR, Graham S, Haughey BP, Shedd D, Dee W. Smoking, alcohol, dentition and diet in the epidemiology of oral cancer. Oral Oncol 1992; 28: 9-15.
6. Mashberg A, Boffetta P, Winkelman R, Garfinkel G. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among US Veterans. Cancer 1993; 72: 1369-75.
7. Degama M, Stern SJ, Martin MV, et al. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res 1994; 54: 4915-9.
8. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999; 35: 173-9.
9. Kouri RE, Mckinney CE, Wray NP, McLemore TL. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 1982; 42: 5030-7.
10. Jaiswal AK, Gonzalez FJ, Nebert DW. Human dioxininducible cytochrome P1-450: complementary DNA and amino acid sequence. Science 1985; 228: 80-2.
11. Petersen DD, McKinney CE, Ikeya K, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 1991; 48: 720-5.
12. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucl Acids Res 1991; 19: 4797-800.
13. Kawajiri K, Fujii-Kuriyama Y. P450 and human cancer. Jpn J Cancer Res 1991; 82: 1325-35.
14. Dipple A. Formation, metabolism, and mechanism of action of polycyclic aromatic hydrocarbons. Cancer Res 1983; 43: 2422-5.
15. Hayashi SI, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione-S-transferase genes. Jpn J Cancer Res 1992; 83: 866-70.
16. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Antila S, Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomark Prev 1992; 1: 485-9.
17. Kawajiri K, Nakachi K, Imai K, Yoshü A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS 1990; 263: 131-3.
18. Park JY, Muscat JE, Ren Q, et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomark Prev 1997; 6: 791-7.
19. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomark Prev 1997; 6: 901-5.
20. Matthias C, Bockmuhl U, Jahnke V, et al. The glutathione-S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998; 8: 1-6.
21. Matthias C, Bockmhl U, Jahnke V, et al. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione-S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998; 8: 91-100.
22. Tanimoto K, Hayashi SI, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 1996; 35: 191-6.
23. Morita S, Yano M, Tsujinaka T, et al. Genetic polymorphisms of drug-metabolizing enzymes susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 1999; 80: 685-8.
24. Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999; 20: 1927-31.
25. Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999; 83: 606-9.
26. Sato M, Sato T, Izumo T, Amagasa T. Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol 2000; 36: 267-71.
27. Olshan AF, Weissler MC, Watson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomark Prev 2000; 9: 185-91.
28. Gustafson S, Proper JA, Walter EJ, Bowie W, Sommer S. Parameters affecting the yield of DNA from human blood. Anal Biochem 1987; 165: 294-9.
29. Taioli E, Chen X, Trachman J, Toniolo P, Garte SJ. A CYP1A1 restriction length polymorphism is associated with breast cancer in African-American women. Cancer Res 1995; 55: 3757-8.
30. Sivaraman L, Leatham P, Yee J, Lau AF. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 1994; 54: 3692-5.
31. Bartsch H, Nair U, Risch A, Rojas M, Wilkman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomark Prev 2000; 9: 3-28.